Studies of Vitamin D supplements on Calcium Metabolism in Sarcoidosis
A one year randomised, double-blind placebo-controlled trial to evaluate the effects of vitamin D supplementation on serum calcium, urine calcium, bone turnover and bone density in subjects with sarcoidosis and vitamin D insufficiency.
Dr Mark Bolland
50 participants
Oct 4, 2007
Interventional
Conditions
Summary
This is a one year study designed to test whether vitamin D supplementation is safe and efficacious for patients with sarcoidosis and low vitamin D levels
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Weekly oral calciferol 50,000 International Units (IU) for four weeks, then monthly oral calciferol 50,000 International Units (IU) for 11 months.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12607000364471